The healthcare sector is undergoing a profound transformation, with innovation emerging as the key driver of growth. In a recent article, Norn Ventures’ Chief Investment Officer, Barry Ritchie, delves into the rapid advancements in digital health, regenerative medicine, artificial intelligence, and robotics that are shaping the future of healthcare investment.

With pharmaceutical companies holding over $1.4 trillion in undeployed capital and the looming “patent cliff” putting billions in annual revenues at risk, the industry is shifting its focus toward breakthrough therapies and next-generation medical technologies. Start-ups pioneering AI-driven diagnostics, gene therapies, and digital health solutions are attracting significant investment, positioning healthcare as one of the most dynamic sectors for growth in the coming years.